Literature DB >> 1962977

Expression of human immunodeficiency virus type 1 gag gene using genetically engineered herpes simplex virus type 1 recombinants.

A Rösen-Wolff1, K Raab, L Zöller, G Darai, J Eberle, F Deinhardt.   

Abstract

Infectious herpes simplex virus type 1 (HSV-1) recombinants were constructed by inserting the cDNA sequence of the human immunodeficiency virus type 1 (HIV-1) gag gene (from nucleotide position 675 [SacI] to 3859 [Asp718] of the cDNA sequences of HIV-1 strain BH-10) within the DNA sequences of the BamHI DNA fragment B of the genome of an apathogenic HSV-1 strain HFEM. This HSV-1 strain possesses a 4.1-kbp deletion within the BamHI DNA fragment B between 0.762 and 0.789 map units of the viral genome, which allows the insertion of at least 4 kbp of foreign genetic material into this particular region. The DNA sequences of the immediate early promoter (IE4) of HSV-1 that were inserted upstream from the gag gene were used as a promoter. The screening of 205 virus stocks derived from individual plaques revealed that 46 recombinant viruses harbor HIV-1 gag-specific DNA sequences. However, it was found that only six of the recombinant viruses are able to express the gag gene product of HIV-1. This indicates that the ratio of the positive recombination events is about 2.9%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1962977     DOI: 10.1007/bf00570027

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  34 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Comparative analysis of the transcripts mapped in the BamHI DNA fragment B of avirulent HSV-1 HFEM, virulent HSV-1 F, and their intratypic recombinant viruses.

Authors:  A Rösen-Wolff; T Ben-Hur; Y Becker; G Darai
Journal:  Virus Res       Date:  1988-06       Impact factor: 3.303

3.  Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; D H Brauer
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment.

Authors:  A Rösen; H Gelderblom; G Darai
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

6.  A sequence in HpaI-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice.

Authors:  Y Becker; J Hadar; E Tabor; T Ben-Hur; I Raibstein; A Rösen; G Darai
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

7.  Determination of the coding capacity of the M genome segment of nephropathia epidemica virus strain Hällnäs B1 by molecular cloning and nucleotide sequence analysis.

Authors:  L B Giebel; R Stohwasser; L Zöller; E K Bautz; G Darai
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

8.  Construction of restriction enzyme fragment libraries containing DNA from human adenovirus types 2 and 5.

Authors:  A Stenlund; M Perricaudet; P Tiollais; U Pettersson
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

9.  An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA.

Authors:  N D Stow; N M Wilkie
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

10.  A herpesvirus vector for expression of glycosylated membrane antigens: fusion proteins of pseudorabies virus gIII and human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  M E Whealy; K Baumeister; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

View more
  1 in total

1.  Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene.

Authors:  D Y Ho; E S Mocarski; R M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.